Radiation quality-dependent bystander effects elicited by targeted radionuclides

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 8, 2008, Pages 951-958

  Boyd, Marie ^a   Sorensen, Annette ^a   McCluskey, Anthony G ^a   Mairs, Robert J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE I 131; 3 ASTATOBENZYLGUANIDINE AT 211; IDOXURIDINE; IDOXURIDINE I 131; RADIOISOTOPE;

BYSTANDER EFFECT; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL CULTURE; CELLULAR DISTRIBUTION; CYTOTOXICITY; GENE; HUMAN; LINEAR ENERGY TRANSFER; MULTICELLULAR SPHEROID; NONHUMAN; NORADRENALIN TRANSPORTER GENE; NUDE MOUSE; RADIATION DOSE; RADIATION EXPOSURE; RADIOIODINATION; RADIOISOTOPE THERAPY; REVIEW; TUMOR XENOGRAFT;

3-IODOBENZYLGUANIDINE; ANIMALS; BYSTANDER EFFECT; CELL DEATH; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IDOXURIDINE; IODINE RADIOISOTOPES; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RADIATION DOSAGE; RADIOPHARMACEUTICALS; SPHEROIDS, CELLULAR; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 47949130909     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.8.0002     Document Type: Review

References (70)

1. Acker, H., Carlsson, J. (1992) The microenviroment in multicellular spheroids. In: Bjerkvig, R. (ed.) Spheroid culture in cancer research. CRC Press, Boca Raton, pp 135-157
2. Azzam, E. I., De Toledo, S. M., Waker, A. J., Little, J. B. (2000) High and low fluences of alpha-particles induce a G1 checkpoint in human diploid fibroblasts. Cancer Res. 60: 2623-2631
3. Azzam, E. I, de Toledo, S. M., Little, J. B. (2001) Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to non-irradiated cells. Proc. Natl Acad. Sci. USA 98: 473-478
4. Belyakov, O. V., Malcolmson, A. M., Folkard, M., Prise, K. M., Michael, B. D. (2001) Direct evidence for a bystander effect of ionizing radiation in primary human fibroblasts. Br. J. Cancer 84: 674-679
5. Belyakov, O. V., Mitchell, S. A., Parikh, D., Randers-Pehrson, G., Marino, S. A., Amundson, S. A., Geard, C. R., Brenner, D. J. (2005) Biological effects in unirradiated human tissue induced by radiation damage up to 1 mm away. Proc Natl Acad Sci USA 102: 14203-14208
6. Bishayee, A., Hill, H. Z., Stein, D., Rao, D. V., Howell, R. W. (2001) Free radical-initiated and gap junction-mediated bystander effect due to nonuniform distribution of incorporated radioactivity in a three-dimensional tissue culture model. Radiat. Res. 155: 335-344
7. Bodei, L., Kassis, A. I., Adelstein, S. J., Mariani, G. (2003) Radionuclide therapy with iodine-125 and other Auger-electron-emitting radionuclides: experimental models and clinical applications. Cancer Biother. Radiopharm. 18: 861-877
8. Boyd, M., Mairs, R. J. (2006) Tumour spheroids. In: Freshney, R. I. (ed.) The culture of animal cells. 5th edn., Alan R. Liss, New York, pp 281-298
9. 131I]meta-iodobenzylguanidine. Gene Ther. 6: 1147-1152
10. Boyd, M., Mairs, S. C., Stevenson, K., Livingstone, A., McCluskey, A. G., Ross, S. C., Mairs, R. J. (2002) Transfectant mosaic spheroids: a new model for the evaluation of bystander effects in experimental gene therapy. J. Gene Med. 4: 567-576
11. Boyd, M., Ross, S. C., Dorrens, J., Fullerton, N. E., Tan, K. W., Zalutsky, M. R., Mairs, R. J. (2006) Radiation induced biological bystander effect elicited in vitro by targeted radiopharmaceuticals labelled with α, β and Auger electron emitting radionuclides. J. Nucl. Med. 47: 1007-1015
12. Bracke, M., Romijn, H., Vakaet, L., Vyncke, B., De Marts, M., Mareel, M. (1992) The use of spheroids in the study of invasion. In: Bjerkvig, R. (ed.) Spheroid culture in cancer research. CRC Press, Boca Raton, pp 73-105
13. Brenner, D. J., Curtis, R. E., Hall, E. J., Ron, E. (2000) Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88: 398-406
14. Bridgewater, J. A., Knox, R. J., Pitts, J. D., Collins, M. K., Springer, C. J. (1997) The bystander effect of the Nitroreductase/CB 1954 Enzyme/Prodrug system is due to a cell-permeable metabolite. Hum. Gene Ther. 8: 709-717
15. 131I]meta-iodobenzylguanidine by neuroblastoma tumours. Clin. Cancer Res. 9: 3338-3344
16. Carlsson, J., Nederman, T. (1992) Tumour spheroids as a model in studies of drug effects. In: Bjerkvig, R. (ed.) Spheroid culture in cancer research. CRC Press, Boca Raton, pp 245-269
17. Cunningham, S. H., Mairs, R. J., Wheldon, T. E., Welsh, P. C., Vaidyanathan, G. Zalutsky, M. R. (1998) Radiotoxicity to neuroblastoma cells and spheroids of beta-, alpha- and Auger electron-emitting conjugates of benzylguanidine. Br. J. Cancer 77: 2061-2068
18. de Jong, M., Bakker, W. H., Breeman, W. A. P. (1998) Pre-clinical comparison of [DTPA0] octreotide, [DTPA0, Tyr3] octreotide and [DOTA0, Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy. Int. J. Cancer 75: 406-411
19. Denning, C., Pitts, J. D. (1997) Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes. Hum. Gene Ther. 8: 1825-1835
20. DeSombre, E. R., Hughes, A., Hanson, R. N., Kearney, T. (2000) Therapy of estrogen receptor-positive micrometastases in the peritoneal cavity with Auger electron-emitting estrogens: theoretical and practical considerations. Acta Oncol. 39: 659-666
21. 131I- labelled E4 antibodies on cells at different depth in DU 145 spheroids. Int. J. Cancer 63: 387-394
22. Gaze, M. N., Huxham, I. M., Mairs, R. J., Barrett, A. (1991) Intracellular localisation of metaiodobenzylguanidine in human neuroblastoma cells by electron spectroscopic imaging. Int. J. Cancer 47: 875-880
23. Gaze, M. N., Mairs, R. J., Boyack, S. M., Wheldon, T. E., Barrett, A. (1992) 131-I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes. Br. J. Cancer 64: 1048-1052
24. Hall, E. J., Hei, T. K. (2003) Genomic instability and bystander effects induced by high-LET radiation. Oncogene 22: 7034-7042
25. Hall, E. J., Wuu, C. S. (2003) Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int. J. Radiat. Oncol. Biol. Phys. 56: 83-88
26. Hjelstuen, M. H., Rasch-Halvorsen, K., Bruland, O., De, L., Davies, C. (1998) Uptake, penetration, and binding of monoclonal antibodies with increasing affinity in human osteosarcoma multicell spheroids. Anticancer Res. 18: 3153-3161
27. Hoefnagel, C. A. (1999) Nuclear medicine therapy of neuroblastoma. Q. J. Nucl. Med. 43: 336-343
28. Iyer, R., Lehnert, B. E. (2000) Factors underlying the cell growth-related bystander responses to alpha particles. Cancer Res. 60: 1290-1298
29. Jacques, S., Tobes, M. C., Sisson, J. C., Baker, J. A. Wieland, D. M. (1984) Comparison of the sodium dependence of uptake of meta-iodobenzylguanidine and norephrine into cultured bovine adrenomedullary cells. Mol. Pharmacol. 26: 539-546
30. Kassis, A. I. (2004) In vivo validation of the bystander effect. Hum. Exp. Toxicol. 23: 71-73
31. Kishikawa, H., Wang, K., Adelstein, S. J., Kassis, A. I. (2006) Inhibitory and stimulatory bystander effects are differentially induced by Iodine-125 and Iodine-123. Radiat. Res. 165: 688-694
32. 131I]meta-iodobenzylguanidine, high dose chemotherapy and immunotherapy. A pilot study. Eur. J. Cancer 34: 1398-1402
33. Knuechel, R., Sutherland, R. M. (1990) Recent developments in research with human tumour spheroids. Cancer J. 3: 234-243
34. Lehnert, B. E., Goodwin, E. H. (1997) Extracellular factor(s) following exposure to alpha particles can cause sister chromatid exchanges in normal human cells. Cancer Res. 57: 2164-2171
35. Little, J. B. (2003) Genomic instability and bystander effects: a historical perspective. Oncogene 22: 6978-6987
36. Lorimore, S. A. Wright, E. G. (2003) Radiation-induced genomic instability and bystander effects: Related inflammatory-type responses to radiation-induced stress and injury? A review. Int. J. Radiat. Biol. 79: 15-25
37. Lybarger, L., Dempsey, D., Franek, K. J., Chervenak, R. (1996) Rapid generation and flow cytometric analysis of stable GFP-expressing cells. Cytometry 25: 211-220
38. Lyng, F. M., Seymour, C. B. Mothersill, C. (2002) Early events in the apoptotic cascade initiated in cells treated with medium from the progeny of irradiated cells. Radiat. Protect. Dosimetry 99: 169-172
39. Mairs, R. J., Boyd, M. (2005) Low dose radiation and bystander effects. Int. J. Radiat. Biol. 81: 259-262
40. Mairs, R. J., Wheldon, T. E. (1996) In: Hagen, U., Harder, D., Jung, H., Streffer, C. (eds) Radiation research 1895-1995; Congress Proceedings. Vol. 2, H. Sturtz, A. G., Wurtzburg: Universitatsdruckerei, pp 819-826.
41. Mairs, R. J., Livingstone, A., Gaze, M. N., Wheldon, T. E., Barrett, A. (1994) Prediction of accumulation of 131I-labelled meta-iodobenzylguanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction. Br. J. Cancer 70: 97-101
42. Mairs, R. J., Ross S. C., McCluskey, A. G., Boyd, M. (2007) A transfectant mosaic xenograft model for the evaluation of targeted radiotherapy in combination with gene therapy in vivo. J. Nucl. Med. 48: 1519-1526
43. Marples, B., Greco, O., Joiner, M. C., Scott, S. D. (2002) Molecular approaches to chemo-radiotherapy. Eur. J. Cancer 38: 231-239
44. Matsumoto, H., Hayashi, S., Hatashita, M., Ohnishi, K., Shioura, H., Ohtsubo, T., Kitai, R., Ohnishi, T., Kano, E. (2001) Induction of radioresistance by a nitric oxide-mediated bystander effect. Radiat. Res. 155: 387-396
45. Mesnil, M., Yamasaki, H. (1999) Bystander effect in suicide gene therapy of cancers. Biogenic Amines 15: 39-52
46. Mitchell, S. A., Randers-Pehrson, G., Brenner, D. J., Hall, E. J. (2004) The bystander response in C3H 10T1/2 cells: the influence of cell-to-cell contact. Radiat. Res. 161: 397-401
47. Morgan, W. F. (2003) Is there a common mechanism underlying genomic instability, bystander effects and other nontargeted effects of exposure to ionising radiation? Oncogene 22: 7094-7099
48. Mothersill, C., Seymour, C. B. (1997) Medium from irradiated human epithelial cells but not human fibroblasts reduced clonogenic survival of unirradiated cells. Int. J. Radiat. Biol. 71: 421-427
49. Mothersill, C., Seymour, C. B. (2001) Radiation induced bystander effects: past history and future directions. Radiat. Res. 155: 759-767
50. Mothersill, C., Seymour C. B. (2002) Bystander and delayed effects after fractionated radiation exposure. Radiat. Res. 158: 626-633
51. Mothersill, C., Seymour, C. B. (2004) Radiation-induced bystander effects - implications for cancer. Nat. Rev. Cancer 4: 158-164
52. Mothersill, C., Moriarty, M. J., Seymour, C. B. (2004) Radiotherapy and the potential exploitation of bystander effects. Int. J. Radiat. Oncol. Biol. Phys. 58: 575-579
53. Mueller-Klieser, W. (1987) Multicellular spheroids. A review on cellular aggregates in cancer research. J. Cancer Res. Clin. Oncol. 113: 101-122
54. Mueller-Klieser, W. (1997) Three-dimensional cell cultures: from molecular mechanisms to clinical applications. Am. J. Physiol. 273: 1109-1123
55. Nagasawa, H., Little, J. B. (1992) Induction of sister chromatid exchanges by extremely low doses of alpha-particles. Cancer Res. 52: 6394-6396
56. Narayanan, P. K., Goodwin, E. H. Lehnert, B. E. (1997) Alpha particles initiate biological production of superoxide anions and hydrogen peroxide in human cells. Cancer Res. 57: 3963-3971
57. Neeman, M., Abramovitch, R., Schiffenbauer, Y. S., Tempel, C. (1997) Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle. Int. J. Exp. Pathol. 78: 57-70
58. 131I] IUDR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire. Br. J. Cancer 77: 385-390
59. Prise, K. M., Schetino, G., Kolkard, M., Held, K. D. (2005) New insights on cell death from radiation exposure. Lancet Oncol. 6: 520-528
60. Rose, B., Matthay, K. K., Price, D., Huberty, J., Klencke, B., Norton, J. A., Fitzgerald, P. A. (2003) High-dose 131I-metaiodobenzyl-guanidine therapy for 12 patients with malignant pheochromocytoma. Cancer 98: 239-248
61. Sastry, K. S. (1992) Biological effects of the Auger emitter iodine-125: a review. Report No. 1 of AAPM Nuclear Medicine Task Group No. 6. Med. Phys. 19: 1361-1370
62. Seymour, C. B., Mothersill, C. (2000) Relative contribution and targeted cell killing to the low-dose region of the radiation dose-response curve. Radiat. Res. 153: 508-511
63. Shao, C., Furusawa, Y., Aoki, M., Matsumoto, H., Ando, K. (2002) Nitric oxide-mediated bystander effect induced by heavy-ions in human salivary gland tumour cells. Int. J. Radiat. Biol. 78: 837-844
64. Simpson, J. K. Gaze, M. N. (1998) Current management of neuroblastoma. Oncologist 3: 253-262
65. 125I]metaiodobenzylguanidine. J. Nucl. Biol. Med. 35: 255-259
66. Sutherland, R. M. (1988) Cell and environment interactions in tumour microregions: the multicell spheroid model. Science 240: 177-184
67. Sutherland, R. M., Inch, W. R., McCredie, J. A. (1970) A multi-component radiation survival curve using an in vitro tumour model. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 18: 491-495
68. Trott, K. R. (2001) Non-targeted effects in radiotherapy: roles of radiation-induced genomic instability and of the bystander effect in cancer cure by radiotherapy. Acta Oncol. 40: 976-980
69. 131I] iodobenzylguanidine. J. Nucl. Med. 21: 349-353
70. Xue, L. Y., Butler, N. J., Makrigiorgos, G. M., Adelstein, S. J., Kassis, A. I. (2002) Bystander effect produced by radiolabelled tumour cells in vivo. Proc. Natl Acad. Sci. USA 99: 13765-13770